ADMA Biologics, Inc. (ADMA) Key Statistics & Financial Ratios

ADMA Biologics, Inc. (ADMA) — Price $8.90 — Healthcare — Biotechnology — NASDAQ

Latest reported results:

Key statistics dashboard for ADMA Biologics, Inc. (ADMA). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.

ADMA Biologics, Inc. functions as a biopharmaceutical company specializing in the development, manufacturing, and commercialization of advanced biologic therapies derived from blood plasma. These specialized products are engineered to address immune system disorders and infectious diseases, catering to markets across the United States and internationally.

Stock Data

Price$8.90
Market Cap$2.1B
Enterprise Value$2.13B
Beta0.82
ExchangeNASDAQ
CountryUS

Valuation Multiples

P/E Ratio12.36
Price / Book4.98
P/S4.03
EV/EBITDA9.07
EV/Sales4.16
EV/FCF18.29
P/FCF17.71
Earnings Yield8.32%
FCF Yield5.65%
Dividend Yield0.00%

Profitability

Gross Margin64.71%
EBIT Margin43.98%
EBITDA Margin45.84%
Operating Margin42.26%
Net Margin32.98%
Return on Equity39.59%
Return on Assets24.69%
Return on Invested Capital27.55%
Return on Capital Employed35.58%

Financial Health

Current Ratio6.97
Quick Ratio3.81
Cash Ratio1.80
Debt / Equity0.50
Debt / Assets29.79%
Net Debt / EBITDA0.29
Interest Coverage24.53
Piotroski F-Score6
Altman Z-Score19.98

Per-Share Data

Revenue per share2.24
Book Value per share1.79
Cash per share0.60
FCF per share0.51
Tangible Book Value per share1.77
Dividend per share0.00

Related companies: ACAD · BLTE · CRNX · DYN · LGND · MIRM · PRAX

Explore sector: Healthcare · Biotechnology

More sections of ADMA: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events

Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks